In its continuing quest to play a part in every step of the cataract procedure Alcon is to acquire LenSx Lasers Inc., for $361.5 million in cash
In its continuing quest to play a part in every step of the cataract procedure Alcon is to acquire LenSx Lasers Inc., for $361.5 million in cash plus maximum contingent payments of $382.5 million based on future revenue targets being achieved and exceeded. The deal will be subject to the required regulatory approvals in the States.
LenSx developed the first femtosecond laser approved by the FDA for use in cataract surgery. In a press statement Stuart Raetzman, vice president, global marketing and area president for the USA said: This complementary technology aligns with Alcon's strategic focus to help surgeons improve every step of the cataract procedure. The LenSx laser provides surgeons a new level of predictability and control over critical manual steps during cataract removal – making those steps more precise and reliable.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.